Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Chromosome Translocations, Gene Fusions, and Their Molecular Consequences in Pleomorphic Salivary Gland Adenomas

G. Stenman, A. Fehr, A. Skálová, V. Vander Poorten, H. Hellquist, LH. Mikkelsen, NF. Saba, O. Guntinas-Lichius, CM. Chiesa-Estomba, MK. Andersson, A. Ferlito

. 2022 ; 10 (8) : . [pub] 20220814

Language English Country Switzerland

Document type Journal Article, Review

Persistent link   https://www.medvik.cz/link/bmc22023530

Salivary gland tumors are a heterogeneous group of tumors originating from the major and minor salivary glands. The pleomorphic adenoma (PA), which is the most common subtype, is a benign lesion showing a remarkable morphologic diversity and that, upon recurrence or malignant transformation, can cause significant clinical problems. Cytogenetic studies of >500 PAs have revealed a complex and recurrent pattern of chromosome rearrangements. In this review, we discuss the specificity and frequency of these rearrangements and their molecular/clinical consequences. The genomic hallmark of PA is translocations with breakpoints in 8q12 and 12q13-15 resulting in gene fusions involving the transcription factor genes PLAG1 and HMGA2. Until recently, the association between these two oncogenic drivers was obscure. Studies of the Silver-Russel syndrome, a growth retardation condition infrequently caused by mutations in IGF2/HMGA2/PLAG1, have provided new clues to the understanding of the molecular pathogenesis of PA. These studies have demonstrated that HMGA2 is an upstream regulator of PLAG1 and that HMGA2 regulates the expression of IGF2 via PLAG1. This provides a novel explanation for the 8q12/12q13-15 aberrations in PA and identifies IGF2 as a major oncogenic driver and therapeutic target in PA. These studies have important diagnostic and therapeutic implications for patients with PA.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22023530
003      
CZ-PrNML
005      
20221031095300.0
007      
ta
008      
221010s2022 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/biomedicines10081970 $2 doi
035    __
$a (PubMed)36009517
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Stenman, Göran $u Sahlgrenska Center for Cancer Research, Department of Pathology, University of Gothenburg, SE-405 30 Gothenburg, Sweden $1 0000000310177363
245    10
$a Chromosome Translocations, Gene Fusions, and Their Molecular Consequences in Pleomorphic Salivary Gland Adenomas / $c G. Stenman, A. Fehr, A. Skálová, V. Vander Poorten, H. Hellquist, LH. Mikkelsen, NF. Saba, O. Guntinas-Lichius, CM. Chiesa-Estomba, MK. Andersson, A. Ferlito
520    9_
$a Salivary gland tumors are a heterogeneous group of tumors originating from the major and minor salivary glands. The pleomorphic adenoma (PA), which is the most common subtype, is a benign lesion showing a remarkable morphologic diversity and that, upon recurrence or malignant transformation, can cause significant clinical problems. Cytogenetic studies of >500 PAs have revealed a complex and recurrent pattern of chromosome rearrangements. In this review, we discuss the specificity and frequency of these rearrangements and their molecular/clinical consequences. The genomic hallmark of PA is translocations with breakpoints in 8q12 and 12q13-15 resulting in gene fusions involving the transcription factor genes PLAG1 and HMGA2. Until recently, the association between these two oncogenic drivers was obscure. Studies of the Silver-Russel syndrome, a growth retardation condition infrequently caused by mutations in IGF2/HMGA2/PLAG1, have provided new clues to the understanding of the molecular pathogenesis of PA. These studies have demonstrated that HMGA2 is an upstream regulator of PLAG1 and that HMGA2 regulates the expression of IGF2 via PLAG1. This provides a novel explanation for the 8q12/12q13-15 aberrations in PA and identifies IGF2 as a major oncogenic driver and therapeutic target in PA. These studies have important diagnostic and therapeutic implications for patients with PA.
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Fehr, Andre $u Sahlgrenska Center for Cancer Research, Department of Pathology, University of Gothenburg, SE-405 30 Gothenburg, Sweden $1 0000000226571392
700    1_
$a Skálová, Alena $u Department of Pathology, Faculty of Medicine, Charles University, 301 66 Plzen, Czech Republic $u Bioptic Laboratory, Ltd., 305 99 Plzen, Czech Republic
700    1_
$a Vander Poorten, Vincent $u Otorhinolaryngology-Head and Neck Surgery, University Hospitals Leuven, 3000 Leuven, Belgium $u Department of Oncology, Section Head and Neck Oncology, KU Leuven, 3000 Leuven, Belgium $1 000000031341829X
700    1_
$a Hellquist, Henrik $u Faculty of Medicine and Biomedical Sciences (FMCB), University of Algarve, 8005-139 Faro, Portugal $u Algarve Biomedical Center Research Institute (ABC-RI), 8005-139 Faro, Portugal $u Northern Lincolnshire and Goole NHS Foundation Trust, Lincoln 999039, UK
700    1_
$a Mikkelsen, Lauge Hjorth $u Department of Pathology, Copenhagen University Hospital, 2100 Copenhagen, Denmark
700    1_
$a Saba, Nabil F $u Department of Hematology and Medical Oncology, The Winship Cancer Institute, Emory University, Atlanta, GA 30322, USA $1 0000000349721477
700    1_
$a Guntinas-Lichius, Orlando $u Department of Otorhinolaryngology, Jena University Hospital, 07747 Jena, Germany $1 0000000196710784
700    1_
$a Chiesa-Estomba, Carlos Miguel $u Department of Otorhinolaryngology-Head and Neck Surgery, Hospital Universitario Donostia, Biodonostia Research Institute, University of Deusto, 20014 San Sebastian, Spain $1 0000000194549464
700    1_
$a Andersson, Mattias K $u Sahlgrenska Center for Cancer Research, Department of Pathology, University of Gothenburg, SE-405 30 Gothenburg, Sweden $1 0000000163912048
700    1_
$a Ferlito, Alfio $u Coordinator of the International Head and Neck Scientific Group, 35122 Padua, Italy $1 0000000282478002
773    0_
$w MED00205373 $t Biomedicines $x 2227-9059 $g Roč. 10, č. 8 (2022)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36009517 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20221010 $b ABA008
991    __
$a 20221031095258 $b ABA008
999    __
$a ind $b bmc $g 1853904 $s 1174818
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 10 $c 8 $e 20220814 $i 2227-9059 $m Biomedicines $n Biomedicines $x MED00205373
LZP    __
$a Pubmed-20221010

Find record

Citation metrics

Archiving options